| BIOGEN INC. DL -,0005 | 258.700 / +11.51% |
| Date/Time | 08/07 / 18:45 |
| Chg. / Chg.(%) | 26.700 / +11.51% |
| Bid | 258.350 / 2000 |
| Ask | 260.100 / 2000 |
| Open | 236.550 |
| Previous Close | 232.000 |
| High | 260.850 |
| Low | 234.900 |
| Volume [EUR] | 25,434.600 |
| Volume [Units] | 102 |
| Price fixings | 8 |
| ISIN | US09062X1037 |
| Security | IDP |
| Exchange | Stuttgart |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 257.150 |  |
|
| NASDAQ | 305.7100 |  |
4,454,612 |
| Cboe US | 305.53 | |
244,727 |
| IEX | 305.57 | |
173,959 |
| London Inter.. | 301.30 | |
4,026 |
| TradeGate | 259.650 | |
3,781 |
| Xetra | 255.45 | |
2,058 |
| Frankfurt | 260.3500 | |
267 |
| Stuttgart | 258.700 | |
102 |
| Vienna Globa.. | 255.35 | |
90 |
| München | 258.00 | |
74 |
| Berlin | 255.95 | |
65 |
| gettex | 260.100 | |
38 |
| Hamburg | 235.25 | |
0 |
| Düsseldorf | 234.25 | |
0 |
| Hannover | 235.80 | |
0 |
| SIX Swiss Ex.. | 232.00 | |
|
| Mexico | 6,007.47 | 16 |
News
- FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer's Disease with Priority Review
08/07/2020 / 13:30 - GlobeNewswire - Trump making it harder to fight pandemic - pharma trade group
08/07/2020 / 01:40 - TeleTrader - Biogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases
08/06/2020 / 14:02 - GlobeNewswire - Biogen to Present Data at Virtual 2020 Alzheimer’s Association International Conference Highlighting Comprehensive Approach to Alzheimer’s Disease
07/24/2020 / 22:06 - GlobeNewswire - Biogen tops estimates with revenue of $3.7B in Q2
07/22/2020 / 12:52 - TeleTrader
Real-time